SION compared with CBLL: revenue, margins and what each company keeps, and the suppliers and customers both name

SIONSionna Therapeutics, Inc.

Mkt capRevenueRevenue

CBLLCeribell, Inc.

Mkt capRevenueRevenue

Compare

SIONSionna Therapeutics, Inc.

CBLLCeribell, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

SIONSionna Therapeutics, Inc.

3.75▲+0.51%· post 3.66· delayed

Mkt cap$168.4MRevenue—Revenue—

CBLLCeribell, Inc.

28.27▲+4.85%· post 25.00· delayed

After hoursNov 3 '26delayed

Mkt cap$1.0BRevenue$29MQ3 FY26Revenue$89MFY25

Compare

After hoursNov 3 '26delayed

SIONSionna Therapeutics, Inc.

CBLLCeribell, Inc.

3.75▲+0.51%post 3.66delayed

Price

28.27▲+4.85%post 25.00delayed

$168.4M

Mkt cap

$1.0B

—

Revenue

$29MQ3 FY26

—

Revenue

$89MFY25

SION3.75▲+0.51%vsCBLL28.27▲+4.85%After hoursNov 3 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SION: latest quarter not drawable. CBLL: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SION 4

ABBVAbbVie Global Enterprises Ltd. ("AbbVie")supplier

SNYSanofi SA ("Sanofi")supplier

—Galapagosunlistedsupplier

—Cystic Fibrosis Foundation (CFF)unlistedsupplier

Shared 0

No disclosed counterparties: CBLL.

Only CBLL 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

SION, solidCBLL, dashed